Bayer CEO: overhaul is leading to pharma pipeline boost
SAN SEBASTIAN (Reuters) -Bayer Chief Executive Bill Anderson said the company is making "remarkable...
22nd September, 2025
SAN SEBASTIAN (Reuters) -Bayer Chief Executive Bill Anderson said the company is making "remarkable...
22nd September, 2025
(Reuters) -Shares in Roche Holding rose around 2% on Monday, outperforming a broadly unchanged Europ...
22nd September, 2025
(Reuters) - British private hospital group Spire Healthcare said on Thursday it had initiated discus...
19th September, 2025
By Maggie Fick and Stine Jacobsen VIENNA (Reuters) - Novo Nordisk might be down but it's not out of...
18th September, 2025
By Olivia Le Poidevin GENEVA (Reuters) -Doctors Without Borders said on Wednesday it was appalled by...
17th September, 2025
H.I.G. Capital portfolio company Iron Bow Technologies has sold its telehealth division SoldierPoint...
17th September, 2025
By Maggie Fick and Mrinalika Roy VIENNA (Reuters) -Eli Lilly has established itself as the market le...
17th September, 2025
VIENNA (Reuters) - Eli Lilly's international president said on Wednesday it was too early to assume...
17th September, 2025
(Reuters) - AstraZeneca said on Wednesday its asthma drug Fasenra failed to control the rate of flar...
17th September, 2025
By Alistair Smout LONDON (Reuters) -Britain needs to reverse its declining spend on medicines, scien...
16th September, 2025
By Deena Beasley (Reuters) -Eli Lilly's experimental weight-loss pill could be fast-tracked under a...
16th September, 2025
(Reuters) -Australia's CSL said on Tuesday it will pay $117 million upfront to Dutch firm VarmX for...
16th September, 2025